Literature DB >> 7258871

Calcitonin as a drug.

L J Deftos, B P First.   

Abstract

Calcitonin is a peptide hormone produced by the C-cells of the thyroid gland. Its main biological effect is to inhibit the resorption of bone. This effect, in combination with a calciuric action of calcitonin, can produce a lowering of blood calcium. These biological effects of calcitonin have made it useful in the treatment of hypercalcemic and hyperresorptive disorders.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7258871     DOI： 10.7326/0003-4819-95-2-192

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


  9 in total

1.  The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat.

Authors:  N Glajchen; S Thomas; P Jowell; S Epstein; F Ismail; M Fallon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

2.  Clinical and Economic Implications of Restrictions on Calcitonin Utilization in a Health System.

Authors:  Samarth P Shah; Michael J Peters; Justin B Usery; Jennifer D Twilla
Journal:  Hosp Pharm       Date:  2019-02-21

3.  The effect of rectal and nasal administration of salmon calcitonin in normal subjects.

Authors:  T Buclin; J P Randin; A F Jacquet; M Azria; M Attinger; F Gomez; P Burckhardt
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

4.  Availability of synthetic salmon calcitonin in tissue fluid after a single intravenous dose.

Authors:  E Concia; M Cruciani; F Bartucci; L Arrigoni; A Longoni
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 5.  Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease.

Authors:  Z M van der Spuy; H S Jacobs
Journal:  Postgrad Med J       Date:  1984-04       Impact factor: 2.401

6.  Calcitonin, estradiol, and hydroxyproline as parameters in the early diagnosis of involutional osteoporosis. The importance of the "second calcitonin phenomenon".

Authors:  L Ferrández; M Martín; M Fernández
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

7.  A new route of drug administration: intrauterine delivery of insulin and calcitonin.

Authors:  G Golomb; A Avramoff; A Hoffman
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

Review 8.  Hypercalcemia of malignancy and new treatment options.

Authors:  Hillel Sternlicht; Ilya G Glezerman
Journal:  Ther Clin Risk Manag       Date:  2015-12-04       Impact factor: 2.423

9.  Unmasking of primary hyperparathyroidism by Vitamin D therapy.

Authors:  S Bala; B Shah; P Rajput; P Rao
Journal:  Indian J Nephrol       Date:  2015 Nov-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.